Information:
Fel:
ID
28939
Beskrivning
Study part: Study Eye Selection Screening. A Phase III, Multicenter, Randomized, Double-Masked, Sham Injection-Controlled Study Of The Efficacy And Safety Of rhuFab V2 (Ranibizumab) In Subjects With Minimally Classic Or Occult Subfoveal Neovascular Age-Related Macular Degeneration.
Nyckelord
Versioner (1)
- 2018-02-18 2018-02-18 -
Rättsinnehavare
Roche
Uppladdad den
18 februari 2018
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Study Eye Selection Screening rhuFab V2 Neovascular Age-Related Macular Degeneration FVF2587grhuFab V2 Neovascular Age-Related Macular Degeneration FVF2598g
Study Eye Selection Screening
- StudyEvent: ODM
Similar models
Study Eye Selection Screening
- StudyEvent: ODM
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Subject Number
Item
Subject Number:
text
C2348585 (UMLS CUI [1])
Subject Initials
Item
Subject Initials:
text
C1997894 (UMLS CUI [1,1])
C2986440 (UMLS CUI [1,2])
C2986440 (UMLS CUI [1,2])
Visit Date
Item
Visit Date:
date
C1320303 (UMLS CUI [1])
CL Item
Right Eye (Right Eye)
C0229089 (UMLS CUI-1)
(Comment:en)
(Comment:en)
CL Item
Left Eye (Left Eye)
C0229090 (UMLS CUI-1)
(Comment:en)
(Comment:en)
CL Item
Both Eyes (Both Eyes)
C0229118 (UMLS CUI-1)
(Comment:en)
(Comment:en)
visual acuity corrected
Item
If Both Eyes is checked, please answer the following question: Was the eye with better best corrected visual acuity enrolled as the study eye?
boolean
C0042812 (UMLS CUI [1,1])
C0205202 (UMLS CUI [1,2])
C0205202 (UMLS CUI [1,2])
indication
Item
If No, explain medical reason for enrolling the worse eye as the study eye:
text
C3146298 (UMLS CUI [1])